Splenic marginal-zone lymphoma: a distinct clinical and pathological entity - The Lancet Oncology
Cleve

Splenic marginal-zone lymphoma: a distinct clinical and pathological entity - The Lancet Oncology

2164 × 1211 px November 8, 2024 Zeus

Splenic marginal-zone lymphoma: a distinct clinical and pathological entity - The Lancet Oncology is a high-quality image in the Cleve collection, available at 2164 × 1211 pixels resolution — ideal for both digital and print use.

Learn about Splenic Marginal Zone Lymphoma (SMZL), a rare B-cell non-Hodgkin lymphoma. Discover the latest clinical insights, common symptoms, diagnostic criteria, and effective treatment options for this slow-growing cancer. Our comprehensive guide helps patients and caregivers understand the prognosis, management strategies, and path forward for navigating this specific hematologic malignancy with confidence.

Image Details

TitleSplenic marginal-zone lymphoma: a distinct clinical and pathological entity - The Lancet Oncology
Dimensions2164 × 1211 px
CategoryCleve
PublishedNovember 8, 2024
AuthorZeus
Downloads380
Views1,755

Frequently Asked Questions

This image has a resolution of 2164 × 1211 pixels. It is suitable for high-quality printing, digital presentations, and web use without losing clarity.
This image is part of the Cleve collection. You can browse more images in this category to find similar content.
Click the Download button above the image to save it directly to your device. The image is provided in its original resolution of 2164 × 1211 px.
Yes! Scroll down to the More Images section below to explore related Cleve images. You can also visit the full article for more context and a complete image gallery.

Read full article: Splenic Marginal Zone Lymphoma